Europe Minimally Invasive Spine Technologies Market: Analysis and Forecast, 2022-2032
À¯·´ÀÇ ÃÖ¼Òħ½À ôÃß ±â¼ú ½ÃÀå ±Ô¸ð´Â 2022³â 6¾ï 9,110¸¸ ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ µ¿¾È 11.84%ÀÇ CAGRÀ» ±â·ÏÇϸç 2032³â 21¾ï 1,650¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ôÃß Ä§½ÀÀ» ÃÖ¼ÒÈÇÏ´Â ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ½ÃÀåÀº ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ½Ã¹Ä·¹À̼Ç, ±³À° ¹× Áö¼ÓÀûÀÎ ÀÇÇÐ ±³À°ÀÇ Á߿伺¿¡ ´ëÇÑ °³¾÷ÀǵéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ºÀå¼¼¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è |
¿¹Ãø ±â°£ |
2022-2032³â |
2022³â Æò°¡ |
6¾ï 9,110¸¸ ´Þ·¯ |
2032³â Àü¸Á |
21¾ï 1,650¸¸ ´Þ·¯ |
CAGR |
11.84% |
À¯·´ÀÇ ÃÖ¼Òħ½À ôÃß ±â¼ú ½ÃÀåÀº ÃÖ¼Òħ½À ôÃß ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ¿Í ½Ã¹Ä·¹À̼Ç, ±³À° ¹× Áö¼ÓÀûÀÎ ÀÇÇÐ ±³À°¿¡ ´ëÇÑ ÀÇ»çÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ħ½À¼ºÀ» ÁÙÀΠôÃß Ä¡·á¿¡ ´ëÇÑ »õ·Î¿î Á¢±Ù ¹æ½ÄÀÌ °¡´ÉÇØÁö¸é¼ ȯÀڵ鿡°Ô ȸº¹ ½Ã°£ ´ÜÃà, ¼ö¼ú ÈÄ ÅëÁõ °¨¼Ò, Á¶Á÷ ¼Õ»ó ÃÖ¼ÒÈ µîÀÇ ÀÌÁ¡À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ôÃß °ü·Ã ÁúȯÀÇ Áõ°¡¿Í °í·ÉÈ »çȸÀÇ È®´ë¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ ¿¹ÈÄ °³¼±°ú ÀÇ·áºñ Àý°¨¿¡ ÁßÁ¡À» µÎ°í ÀÖ´Â À¯·´¿¡¼´Â ÃÖ¼Òħ½ÀÀû ôÃß ±â¼ú äÅÃÀÌ Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ôÃß Ä¡·áÀÇ Àü¸ÁÀ» À籸¼ºÇϰí ÀÌ Áö¿ª ÀÇ·á ¼ºñ½ºÀÇ Àü¹ÝÀûÀÎ °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
À¯·´ÀÇ ÃÖ¼Òħ½À ôÃß ±â¼ú ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¢Á¾ ¿äÀÎ ºÐ¼®, ±â¼ú¡¤Æ¯Çã µ¿Çâ, Á¦Ç° º¥Ä¡¸¶Å·, ÀÓ»ó½ÃÇè µ¿Çâ, ±ÔÁ¦ ȯ°æ, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ ºÐ¼® µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
½ÃÀå ºÐ·ù
¼¼ºÐÈ 1: ±¹°¡º°
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ
¸ñÂ÷
ÁÖ¿ä ¿ä¾à
Á¶»ç ¹üÀ§
Á¶»ç ¹æ¹ý
Á¦1Àå ½ÃÀå
- ¼¼°è ½ÃÀå Àü¸Á
- ½ÃÀå °³¿ä
- Á¦Ç°ÀÇ Á¤ÀÇ
- Æ÷ÇÔ ±âÁذú Á¦¿Ü ±âÁØ
- ÁÖ¿ä Á¶»ç °á°ú
- °¡Á¤°ú Á¦ÇÑ»çÇ×
- ½ÃÀå ¼ºÀå ½Ã³ª¸®¿À
- ¾÷°è Àü¸Á
- ÁÖ¿ä µ¿Çâ
- ±âȸ Æò°¡
- ƯÇ㠺м®
- Á¦Ç° º¥Ä¡¸¶Å·
- ÀÓ»ó½ÃÇè
- ÃÖ¼Òħ½À ôÃß ±â¼ú¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
- »ç¾÷ ¿ªÇÐ
- ¿µÇ⠺м®
- »ç¾÷ ÃËÁø¿äÀÎ
- »ç¾÷»ó Á¦¾à
- »ç¾÷ ±âȸ
Á¦2Àå À¯·´
- À¯·´ÀÇ ÃÖ¼Òħ½À ôÃß ±â¼ú ½ÃÀå
- ±ÔÁ¦ ü°è
- ÁÖ¿ä Á¶»ç °á°ú¿Í ±âȸ Æò°¡
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
Á¦3Àå °æÀï º¥Ä¡¸¶Å·°ú ±â¾÷ °³¿ä
- °æÀï »óȲ
- ±â¾÷ °³¿ä
- AMS Group
- B. Braun SE
- Medtronic plc
- Richard Wolf GmbH
- Spineart
ksm
“The Europe Minimally Invasive Spine Technologies Market Expected to Reach $2,116.5 Million by 2032.”
Introduction to Europe Minimally Invasive Spine Technologies Market
The Europe minimally invasive spine technologies market was valued at $691.1 million in 2022 and is anticipated to reach $2,116.5 million by 2032, witnessing a CAGR of 11.84% during the forecast period 2022-2032. The market for minimally invasive spine technologies is anticipated to experience growth due to the increasing preference for surgical procedures that involve minimal invasion in the spine. Additionally, practitioners' growing awareness regarding the importance of simulation, training, and ongoing medical education is expected to contribute to this upward trend.
KEY MARKET STATISTICS |
Forecast Period | 2022 - 2032 |
2022 Evaluation | $691.1 Million |
2032 Forecast | $2,116.5 Million |
CAGR | 11.84% |
Market Introduction
The Europe Minimally Invasive Spine Technologies Market is experiencing significant growth, propelled by the increasing favoritism toward less invasive spinal procedures and heightened awareness among practitioners regarding simulation, training, and continuous medical education. Advancements in medical technologies are enabling novel approaches to spinal interventions that involve reduced invasiveness, providing patients with benefits such as shorter recovery times, diminished postoperative pain, and minimized tissue damage. The market is responding to a growing incidence of spine-related disorders and an expanding aging population. With a focus on enhancing patient outcomes and curbing healthcare costs, the adoption of minimally invasive spine technologies in Europe is poised for ongoing expansion. This trend is reshaping the landscape of spinal interventions and contributing to the overall improvement of healthcare delivery in the region.
Market Segmentation:
Segmentation 1: by Country
- Germany
- France
- U.K.
- Italy
- Spain
- Rest-of-Europe
How can this report add value to an organization?
Growth/Marketing Strategy: The Europe minimally invasive spine technologies market has seen major developments by key players operating in the market, such as partnerships, collaborations and business expansions, mergers and acquisitions, product launches, and funding activities. The favored strategy for the companies has been new offerings in the minimally invasive spine technologies market.
Competitive Strategy: Key players in the Europe minimally invasive spine technologies market analyzed and profiled in the study involve players that offer surgical systems, instruments, and systems. Moreover, a detailed market share analysis of the players operating in the Europe minimally invasive spine technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The featured companies have been meticulously chosen, drawing insights from primary experts and thorough evaluations of company coverage, product offerings, and market presence.
Some prominent names established in this market are:
- AMS Group
- B. Braun SE
- Medtronic plc
|
- Richard Wolf GmbH
- Spineart
|
Table of Contents
Executive Summary
Scope of the Study
Research Methodology
1. Markets
- 1.1. Global Market Outlook
- 1.1.1. Market Overview
- 1.1.2. Product Definition
- 1.1.3. Inclusion and Exclusion Criteria
- 1.1.4. Key Findings
- 1.1.5. Assumptions and Limitations
- 1.1.6. Market Growth Scenario
- 1.1.6.1. Realistic Growth Scenario
- 1.1.6.2. Optimistic Growth Scenario
- 1.1.6.3. Pessimistic Growth Scenario
- 1.2. Industry Outlook
- 1.2.1. Key Trends
- 1.2.2. Opportunity Assessment
- 1.2.3. Patent Analysis
- 1.2.3.1. Awaited Technological Developments
- 1.2.3.2. Patent Filing Trend (by Country)
- 1.2.3.3. Patent Filing Trend (by Year)
- 1.2.4. Product Benchmarking
- 1.2.5. Clinical Trials
- 1.3. Impact of COVID-19 on the Minimally Invasive Spine Technologies
- 1.3.1. Pre-COVID-19 Phase
- 1.3.2. During COVID-19
- 1.3.3. Post-COVID-19 Phase
- 1.3.3.1. Impact on Demand and Supply
- 1.3.3.2. Impact on Competitive Landscape
- 1.3.3.3. Impact on Company Revenue
- 1.4. Business Dynamics
- 1.4.1. Impact Analysis
- 1.4.2. Business Drivers
- 1.4.2.1. Increasing Incidences and Prevalence of Spinal Disorders
- 1.4.2.2. Increasing Preference for Minimally Invasive Spine Surgeries
- 1.4.2.3. Technological Advancement in Minimally Invasive Spine Surgical Procedures
- 1.4.3. Business Restraints
- 1.4.3.1. Lack of Well-Established Landscape for Reimbursement for Minimally Invasive Spinal Procedures
- 1.4.3.2. Factors Hindering the Implementation of Minimally Invasive Spinal Surgeries
- 1.4.3.2.1. High Cost of Capital Equipment Purchases and Disposables
- 1.4.3.2.2. Lack of Training Leading to Shortage of Skilled Professionals
- 1.4.4. Business Opportunities
- 1.4.4.1. Augmentation of Artificial Intelligence in Minimally Invasive Spine Surgery
- 1.4.4.2. Leveraging Synergies to Diversify Business Portfolio
2. Europe
- 2.1. Europe Minimally Invasive Spine Technologies Market
- 2.1.1. Regulatory Framework
- 2.1.1.1. Spinal Classification EU MDR Model Proposed by Team NB
- 2.1.2. Key Findings and Opportunity Assessment
- 2.1.3. Market Dynamics
- 2.1.4. Market Sizing and Forecast
- 2.1.4.1. Europe Minimally Invasive Spine Technologies Market (by Country)
- 2.1.4.1.1. Germany
- 2.1.4.1.1.1. Market Dynamics
- 2.1.4.1.1.2. Market Size and Forecast
- 2.1.4.1.2. U.K.
- 2.1.4.1.2.1. Market Dynamics
- 2.1.4.1.2.2. Market Size and Forecast
- 2.1.4.1.3. France
- 2.1.4.1.3.1. Market Dynamics
- 2.1.4.1.3.2. Market Size and Forecast
- 2.1.4.1.4. Italy
- 2.1.4.1.4.1. Market Dynamics
- 2.1.4.1.4.2. Market Size and Forecast
- 2.1.4.1.5. Spain
- 2.1.4.1.5.1. Market Dynamics
- 2.1.4.1.5.2. Market Size and Forecast
- 2.1.4.1.6. Rest-of-Europe
- 2.1.4.1.6.1. Market Dynamics
- 2.1.4.1.6.2. Market Size and Forecast
3. Competitive Benchmarking and Company Profiles
- 3.1. Competitive Landscape
- 3.1.1. Key Strategies and Developments
- 3.1.1.1. Regulatory and Legal Activities
- 3.1.1.2. New Offerings
- 3.1.1.3. Mergers and Acquisitions
- 3.1.1.4. Partnerships, Collaborations, and Business Expansions
- 3.2. Company Profiles
- 3.2.1. AMS Group
- 3.2.1.1. Company Overview
- 3.2.1.2. Role of AMS Group in the Minimally Invasive Spine Technologies Market
- 3.2.1.3. Analyst Perspective
- 3.2.2. B. Braun SE
- 3.2.2.1. Company Overview
- 3.2.2.2. Role of B. Braun SE in the Minimally Invasive Spine Technologies Market
- 3.2.2.3. Product Portfolio
- 3.2.2.4. Financials
- 3.2.2.5. Analyst Perception
- 3.2.3. Medtronic plc
- 3.2.3.1. Company Overview
- 3.2.3.2. Role of Medtronic plc in the Minimally Invasive Spine Technologies Market
- 3.2.3.3. Product Portfolio
- 3.2.3.4. Financials
- 3.2.3.5. Recent Developments
- 3.2.3.6. Analyst Perception
- 3.2.4. Richard Wolf GmbH
- 3.2.4.1. Company Overview
- 3.2.4.2. Role of Richard Wolf GmbH in the Minimally Invasive Spine Technologies Market
- 3.2.4.3. Analyst Perspective
- 3.2.5. Spineart
- 3.2.5.1. Company Overview
- 3.2.5.2. Role of Spineart in the Minimally Invasive Spine Technologies Market
- 3.2.5.3. Recent Developments
- 3.2.5.4. Analyst Perspective